93 related articles for article (PubMed ID: 19447592)
21. Oxidized low density lipoprotein decreases Rankl-induced differentiation of osteoclasts by inhibition of Rankl signaling.
Mazière C; Louvet L; Gomila C; Kamel S; Massy Z; Mazière JC
J Cell Physiol; 2009 Dec; 221(3):572-8. PubMed ID: 19725047
[TBL] [Abstract][Full Text] [Related]
22. Stimulatory effect of hydrothermally synthesized biodegradable hydroxyapatite granules on osteogenesis and direct association with osteoclasts.
Gonda Y; Ioku K; Shibata Y; Okuda T; Kawachi G; Kamitakahara M; Murayama H; Hideshima K; Kamihira S; Yonezawa I; Kurosawa H; Ikeda T
Biomaterials; 2009 Sep; 30(26):4390-400. PubMed ID: 19481798
[TBL] [Abstract][Full Text] [Related]
23. High molecular weight hyaluronic acid regulates osteoclast formation by inhibiting receptor activator of NF-κB ligand through Rho kinase.
Ariyoshi W; Okinaga T; Knudson CB; Knudson W; Nishihara T
Osteoarthritis Cartilage; 2014 Jan; 22(1):111-20. PubMed ID: 24185105
[TBL] [Abstract][Full Text] [Related]
24. Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells.
Dalbeth N; Smith T; Nicolson B; Clark B; Callon K; Naot D; Haskard DO; McQueen FM; Reid IR; Cornish J
Arthritis Rheum; 2008 Jun; 58(6):1854-65. PubMed ID: 18512794
[TBL] [Abstract][Full Text] [Related]
25. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
[TBL] [Abstract][Full Text] [Related]
26. Proteomic profile of osteoclast membrane proteins: identification of Na+/H+ exchanger domain containing 2 and its role in osteoclast fusion.
Ha BG; Hong JM; Park JY; Ha MH; Kim TH; Cho JY; Ryoo HM; Choi JY; Shin HI; Chun SY; Kim SY; Park EK
Proteomics; 2008 Jul; 8(13):2625-39. PubMed ID: 18600791
[TBL] [Abstract][Full Text] [Related]
27. YY1 is involved in RANKL-induced transcription of the tartrate-resistant acid phosphatase gene in osteoclast differentiation.
Shi Z; Silveira A; Patel P; Feng X
Gene; 2004 Dec; 343(1):117-26. PubMed ID: 15563837
[TBL] [Abstract][Full Text] [Related]
28. Mechanical stress directly suppresses osteoclast differentiation in RAW264.7 cells.
Suzuki N; Yoshimura Y; Deyama Y; Suzuki K; Kitagawa Y
Int J Mol Med; 2008 Mar; 21(3):291-6. PubMed ID: 18288375
[TBL] [Abstract][Full Text] [Related]
29. Difference between dogs and rats with regard to osteoclast-like cells in calcium-deficient hydroxyapatite-induced osteoinduction.
Akiyama N; Takemoto M; Fujibayashi S; Neo M; Hirano M; Nakamura T
J Biomed Mater Res A; 2011 Feb; 96(2):402-12. PubMed ID: 21171160
[TBL] [Abstract][Full Text] [Related]
30. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid.
Rahman MM; Bhattacharya A; Fernandes G
J Cell Physiol; 2008 Jan; 214(1):201-9. PubMed ID: 17929247
[TBL] [Abstract][Full Text] [Related]
31. Effects of soluble cobalt and cobalt incorporated into calcium phosphate layers on osteoclast differentiation and activation.
Patntirapong S; Habibovic P; Hauschka PV
Biomaterials; 2009 Feb; 30(4):548-55. PubMed ID: 18996589
[TBL] [Abstract][Full Text] [Related]
32. Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression.
Hounoki H; Sugiyama E; Mohamed SG; Shinoda K; Taki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Miyahara T
Bone; 2008 Apr; 42(4):765-74. PubMed ID: 18242157
[TBL] [Abstract][Full Text] [Related]
33. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene.
Matsuzaki K; Katayama K; Takahashi Y; Nakamura I; Udagawa N; Tsurukai T; Nishinakamura R; Toyama Y; Yabe Y; Hori M; Takahashi N; Suda T
Endocrinology; 1999 Feb; 140(2):925-32. PubMed ID: 9927325
[TBL] [Abstract][Full Text] [Related]
34. Osteoclast precursors circulate in avian blood.
Alvarez JI; Ross FP; Athanasou NA; Blair HC; Greenfield EM; Teitelbaum SL
Calcif Tissue Int; 1992 Jul; 51(1):48-53. PubMed ID: 1393777
[TBL] [Abstract][Full Text] [Related]
35. Endogenous expression and endocytosis of tartrate-resistant acid phosphatase (TRACP) by osteoblast-like cells.
Perez-Amodio S; Vogels IM; Schoenmaker T; Jansen DC; Alatalo SL; Halleen JM; Beertsen W; Everts V
Bone; 2005 Jun; 36(6):1065-77. PubMed ID: 15878315
[TBL] [Abstract][Full Text] [Related]
36. High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells.
Mozar A; Haren N; Chasseraud M; Louvet L; Mazière C; Wattel A; Mentaverri R; Morlière P; Kamel S; Brazier M; Mazière JC; Massy ZA
J Cell Physiol; 2008 Apr; 215(1):47-54. PubMed ID: 17894387
[TBL] [Abstract][Full Text] [Related]
37. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts.
Luchin A; Purdom G; Murphy K; Clark MY; Angel N; Cassady AI; Hume DA; Ostrowski MC
J Bone Miner Res; 2000 Mar; 15(3):451-60. PubMed ID: 10750559
[TBL] [Abstract][Full Text] [Related]
38. Sequence and TLR9 independent increase of TRACP expression by antisense DNA and siRNA molecules.
Muhonen P; Avnet S; Parthasarathy RN; Janckila AJ; Halleen JM; Laitala-Leinonen T; Väänänen HK
Biochem Biophys Res Commun; 2007 Aug; 359(4):889-95. PubMed ID: 17570345
[TBL] [Abstract][Full Text] [Related]
39. IL-13 as well as IL-4 induces monocytes/macrophages and a monoblastic cell line (UG3) to differentiate into multinucleated giant cells in the presence of M-CSF.
Ikeda T; Ikeda K; Sasaki K; Kawakami K; Hatake K; Kaji Y; Norimatsu H; Harada M; Takahara J
Biochem Biophys Res Commun; 1998 Dec; 253(2):265-72. PubMed ID: 9878526
[TBL] [Abstract][Full Text] [Related]
40. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
